Gary K. Lee

Insider Reports History

Entity
Individual
Location
C/O Lyell Immunopharma, Inc., 201 Haskins Way, South San Francisco, CA
Signature
/s/ Matthew Lang, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gary K. Lee:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Scientific Officer Common Stock 52.7K $120K $2.28 Feb 9, 2024 Direct
Lyell Immunopharma, Inc. Chief Scientific Officer Stock Option (right to buy) 400K Feb 9, 2024 Direct

Insider Reports Filed by Gary K. Lee

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Feb 9, 2024 2 $0 4 Feb 13, 2024 Chief Scientific Officer
LYEL Lyell Immunopharma, Inc. Nov 16, 2023 2 $0 4 Nov 20, 2023 Chief Scientific Officer
LYEL Lyell Immunopharma, Inc. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Scientific Officer
LYEL Lyell Immunopharma, Inc. Feb 11, 2022 1 $0 4 Feb 14, 2022 Chief Scientific Officer
LYEL Lyell Immunopharma, Inc. Jan 31, 2022 0 $0 3 Feb 4, 2022 Chief Scientific Officer